Trials / Completed
CompletedNCT00094627
Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Adult Patients With Primary Insomnia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 465 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | gaboxadol | Duration of Treatment - 6 weeks |
| DRUG | Comparator: placebo (unspecified) | Duration of Treatment - 6 weeks |
Timeline
- Start date
- 2004-11-01
- Completion
- 2006-04-01
- First posted
- 2004-10-22
- Last updated
- 2015-01-14
Source: ClinicalTrials.gov record NCT00094627. Inclusion in this directory is not an endorsement.